Titlebook: Beyond Assessment of Quality of Life in Schizophrenia; A. George Awad,Lakshmi N.P. Voruganti Book 2016 Springer International Publishing S

評論者

浮夸

Oussama Nabil Bessaid,Chahrazed Benyahiancy of the discussion in this chapter, it’s important to understand how terminology from other scientific disciplines is used across healthcare and pharmaceutical industries that describes, or simply refers to, psychometric measurement and the tools that are used for such purpose.

forecast

https://doi.org/10.1007/978-3-030-49795-8n medicine (see Fig. 5.1). Its evaluation is founded on the notion that every patient has a right to self-determination in health-care decisions and his/her subjective perspective should be considered in both diagnosis and care planning processes (Awad and Voruganti 2012; Badia et al. 1999; Bilker et al. 2003).

嚙齒動物

TRACE

MIME

A Review of Quality-of-Life Assessment Measures in Schizophrenia: Limitations and Future Developmentn medicine (see Fig. 5.1). Its evaluation is founded on the notion that every patient has a right to self-determination in health-care decisions and his/her subjective perspective should be considered in both diagnosis and care planning processes (Awad and Voruganti 2012; Badia et al. 1999; Bilker et al. 2003).

車床

Conglin Gao,Shouyin Lu,Xinjian Gu,Xinyun Huromised by a high risk of medication nonadherence and service disengagement (Velligan et al. 2009) and of comorbid disorders, especially substance use (Fleischhacker et al. 2008). All these factors directly or indirectly mediate QOL in patients with schizophrenia.

ABOUT

Xiaojie Zhou,Shuai Wang,Cheng Zhang in the management of schizophrenia. One of the approaches proposed for cost-effectiveness studies capitalized on utility analysis concepts, which incorporates cost and quality of life. This chapter describes our feasibility study of applying utility concepts to schizophrenia, highlighting its merits and limitations.

Intervention

Metamorphosis

Quality of Life as an Outcome and a Mediator of Other Outcomes in Patients with Schizophreniaromised by a high risk of medication nonadherence and service disengagement (Velligan et al. 2009) and of comorbid disorders, especially substance use (Fleischhacker et al. 2008). All these factors directly or indirectly mediate QOL in patients with schizophrenia.